2,4-thiazolidinedione has been researched along with Astrocytoma, Grade IV in 3 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Excerpt | Relevance | Reference |
---|---|---|
"Glioblastomas represent 15% of brain tumors." | 2.58 | Peroxisome proliferator-activated receptor gamma: promising target in glioblastoma. ( Chellappan, DK; Dahiya, R; de Jesus Andreoli Pinto, T; Dua, K; Gupta, G; Mishra, A; Sharma, S; Singhvi, G, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Sheu, ML | 1 |
Pan, LY | 1 |
Hu, HY | 1 |
Su, HL | 1 |
Sheehan, J | 1 |
Tsou, HK | 1 |
Pan, HC | 1 |
Gupta, G | 1 |
Singhvi, G | 1 |
Chellappan, DK | 1 |
Sharma, S | 1 |
Mishra, A | 1 |
Dahiya, R | 1 |
de Jesus Andreoli Pinto, T | 1 |
Dua, K | 1 |
de Vasconcelos, A | 1 |
de Moura, LR | 1 |
Pedra, NS | 1 |
Bona, NP | 1 |
Soares, MSP | 1 |
da Silva Marques, M | 1 |
Horn, AP | 1 |
Spohr, L | 1 |
Spanevello, RM | 1 |
Stefanello, FM | 1 |
Cunico, W | 1 |
1 review available for 2,4-thiazolidinedione and Astrocytoma, Grade IV
Article | Year |
---|---|
Peroxisome proliferator-activated receptor gamma: promising target in glioblastoma.
Topics: Animals; Brain Neoplasms; Glioblastoma; Glucose; Humans; Insulin; Ligands; Lipids; Mice; PPAR gamma; | 2018 |
2 other studies available for 2,4-thiazolidinedione and Astrocytoma, Grade IV
Article | Year |
---|---|
Potential Therapeutic Effects of Thiazolidinedione on Malignant Glioma.
Topics: Animals; Cell Cycle Proteins; Cell Line, Tumor; Diabetes Mellitus, Type 2; Glioblastoma; Glioma; Hyp | 2022 |
Thiazolidine-2,4-dione derivative exhibits antitumoral effect and reverts behavioral and metabolic changes in a model of glioblastoma.
Topics: Animals; Glioblastoma; Male; Rats; Rats, Wistar; Thiazolidinediones; Thiazolidines | 2022 |